Additionally, a single animal model is unable to fully recapitulate all of the features of human ARDS [13], therefore providing further reason to evaluate the efficacy of CNP-miR146a as a potential therapeutic for ARDS in a model of infectious pneumonia. The gene discussed is CNP; the disease is acute respiratory distress syndrome.